These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11716163)

  • 21. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
    Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
    Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy.
    Mastronardi L; Puzzilli F; Guiducci A
    Neurosurgery; 1998 Dec; 43(6):1496. PubMed ID: 9848870
    [No Abstract]   [Full Text] [Related]  

  • 23. p53 protein in non-small cell lung cancer as quantitated by enzyme-linked immunosorbent assay: relation to prognosis.
    Pappot H; Francis D; Brünner N; Grondahl-Hansen J; Osterlind K
    Clin Cancer Res; 1996 Jan; 2(1):155-60. PubMed ID: 9816102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer.
    Cheng YL; Lee SC; Harn HJ; Chen CJ; Chang YC; Chen JC; Yu CP
    Eur J Cardiothorac Surg; 2003 Feb; 23(2):221-8. PubMed ID: 12559346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death in resectable non-small cell lung cancer.
    Pollán M; Varela G; Torres A; de la Torre M; Ludeña MD; Ortega MD; Pac J; Freixenet J; Gómez G; Sebastián F; Díez M; Arrabal R; Canalís E; García-Tirado J; Arnedillo A; Rivas JJ; Minguella J; Gómez A; García M; Aragonés N; Pérez-Gómez B; López-Abente G; González-Sarmiento R; Rojas JM
    Int J Cancer; 2003 Dec; 107(5):781-90. PubMed ID: 14566828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
    Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined analysis of p53 and retinoblastoma protein expressions in esophageal cancer.
    Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
    Ann Thorac Surg; 2000 Sep; 70(3):913-7. PubMed ID: 11016333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular marker as an indicator in presaging prognosis of human lung adenocarcinoma].
    Zhou B; Dai X; He A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Aug; 19(4):231-3. PubMed ID: 10322679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 expression and prognosis in gastric carcinoma.
    Martin HM; Filipe MI; Morris RW; Lane DP; Silvestre F
    Int J Cancer; 1992 Apr; 50(6):859-62. PubMed ID: 1555884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical detection of P53 protein is not associated with a poor prognosis in non-small-cell lung cancer.
    Passlick B; Izbicki JR; Häussinger K; Thetter O; Pantel K
    J Thorac Cardiovasc Surg; 1995 Jun; 109(6):1205-11. PubMed ID: 7776684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of malignancy of squamous cell lung cancer by clinico-morphological, immunohistochemical and prognostic study of tumor markers].
    Shvets SI; Kogan EA; Kovalenko VL; Soboleva IuV
    Vopr Onkol; 2009; 55(6):746-50. PubMed ID: 20210019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
    Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
    Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Overexpression of p53 protein in ovarian carcinomas: correlation with histopathologic data and clinical course].
    Reles A; Press MF; Schönborn I; Lichtenegger W; Strohmeyer T
    Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():93-7. PubMed ID: 8672936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of apoptotic index in non-small cell lung cancer: correlation with p53, mdm2, pRb and p21WAF1/CIP1 protein expression.
    Dworakowska D; Jassem E; Jassem J; Karmoliński A; Dworakowski R; Wirth T; Gruchała M; Rynkiewicz A; Skokowski J; Yla-Herttuala S; Jaśkiewicz K; Czestochowska E
    J Cancer Res Clin Oncol; 2005 Sep; 131(9):617-23. PubMed ID: 16028106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chaperone protein L-isoaspartate (D-aspartyl) O-methyltransferase as a novel predictor of poor prognosis in lung adenocarcinoma.
    Saito H; Yamashita M; Ogasawara M; Yamada N; Niisato M; Tomoyasu M; Deguchi H; Tanita T; Ishida K; Sugai T; Yamauchi K
    Hum Pathol; 2016 Apr; 50():1-10. PubMed ID: 26997432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in phyllodes tumor of the breast: are immunohistochemical biomarkers useful?
    Chu JS
    J Chin Med Assoc; 2004 Jan; 67(1):1-2. PubMed ID: 15077882
    [No Abstract]   [Full Text] [Related]  

  • 37. Diagnosis: Early warning system.
    Bourzac K
    Nature; 2014 Sep; 513(7517):S4-6. PubMed ID: 25208071
    [No Abstract]   [Full Text] [Related]  

  • 38. Prognostic value of p53 in non-small cell lung cancer: relationship with proliferating cell nuclear antigen and cigarette smoking.
    Esposito V; Baldi A; De Luca A; Micheli P; Mazzarella G; Baldi F; Caputi M; Giordano A
    Hum Pathol; 1997 Feb; 28(2):233-7. PubMed ID: 9023408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor angiogenesis and biologic markers in resected stage I NSCLC.
    Lucchi M; Fontanini G; Mussi A; Vignati S; Ribechini A; Menconi GF; Bevilacqua G; Angeletti CA
    Eur J Cardiothorac Surg; 1997 Oct; 12(4):535-41. PubMed ID: 9370395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic value of the molecular markers cyclin D1 and P53 in patients with lung cancer].
    Uchikov A; Hadjiev B; Dimitrov I; Prisadov G; Uchikova E; Batashki A; Ganchevska P
    Khirurgiia (Sofiia); 2010; (6):19-22. PubMed ID: 21972713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.